NCT02705560

Brief Summary

Dietary biomarkers are compounds in biofluids that directly reflect the intake of specific foods or food groups. Their exploration and use in the field of dietary assessments could provide an objective measure of actual intake complementing classical assessment methods (e.g. food frequency questionnaire, 24h recalls). To date, only a limited number of foods have been covered by validated biomarkers. The study is part of the international project "The Food Biomarker Alliance (FOODBALL)". The study described here has been assigned to assess biomarkers of the intake of milk and cheese. Up to now, there is an evident lack of data on specific and validated biomarkers of milk and cheese (dairy products), which belong to the most relevant public health related foods in Europe. This study will further provide novel insights into the influence of fermentation of milk-based foods on metabolic effects and postprandial adaptations, which has not yet been studied in depth before using cheese as fermented product. Outcomes will support and expand earlier findings on correlation between the intake of fermented dairy products intake and human health.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12

participants targeted

Target at below P25 for not_applicable healthy

Timeline
Completed

Started Aug 2015

Longer than P75 for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2015

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

March 5, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 10, 2016

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2018

Completed
Last Updated

March 10, 2016

Status Verified

March 1, 2016

Enrollment Period

10 months

First QC Date

March 5, 2016

Last Update Submit

March 5, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Identification of dietary biomarkers of cheese and milk intake

    24 hours

Secondary Outcomes (8)

  • Transcriptomics analyses / gene expression

    6 hours

  • Blood cell count and cell type determination

    6 hours

  • Glucose

    24 hours

  • Insulin

    24 hours

  • Triacylglycerides

    24 hours

  • +3 more secondary outcomes

Study Arms (3)

Cow´s milk (3.9% fat, pasteurized)

EXPERIMENTAL

Cow´s milk (3.9% fat, pasteurized) Single dose, 600 ml milk

Other: Cow´s milk (3.9% fat, pasteurized)

Hard, yellow cheese

EXPERIMENTAL

Hard, yellow cheese Single dose, 100 g cheese \+ 500 ml water

Other: hard, yellow cheese

Soy based drink

ACTIVE COMPARATOR

Soy based drink Single dose, 600 ml soy drink (soy drink + plant based cream)

Other: Soy based drink

Interventions

600 ml full fat milk (organic, pasteurized, 400 kcal)

Cow´s milk (3.9% fat, pasteurized)

100 g Swiss cheese (Le Gruyère medium ripe, 400 kcal)

Hard, yellow cheese

600 ml Soy drink (540 ml soy milk (232 kcal) supplemented with 60 ml soy and plant based cream (167 kcal)

Soy based drink

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy males and females
  • Aged 18 - 40 years
  • BMI \> 18.5 and \< 30 kg/m2
  • Daily consumption of milk
  • No adverse effects after intake of 600 ml of milk

You may not qualify if:

  • Smokers
  • Diagnosed health condition (chronic or infectious disease)
  • Taking medication (oral contraceptive pill is allowed)
  • Taking nutritional supplements (e.g. vitamins, minerals)
  • Pregnant, lactating
  • Antibiotics treatment 6 months prior to intervention
  • Allergy to milk
  • Allergy to soy
  • Known intolerance to lactose
  • Other food allergies or intolerances (e.g. histamine)
  • Anemia (hemoglobin \< 120 g/l) at the screening visit
  • Iron deficiency (ferritin \< 30 µg/l) at the screening visit
  • Not willing/able to consume all test foods (milk, cheese and soy drink)
  • Not willing/able to consume standardized meals
  • Not willing to avoid drinking alcohol during study days
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service of Endocrinology, Diabetes and Metabolism, University Hospital, CHUV

Lausanne, Canton of Vaud, 1011, Switzerland

RECRUITING

Related Publications (2)

  • Pimentel G, Burnand D, Munger LH, Pralong FP, Vionnet N, Portmann R, Vergeres G. Identification of Milk and Cheese Intake Biomarkers in Healthy Adults Reveals High Interindividual Variability of Lewis System-Related Oligosaccharides. J Nutr. 2020 May 1;150(5):1058-1067. doi: 10.1093/jn/nxaa029.

  • Munger LH, Trimigno A, Picone G, Freiburghaus C, Pimentel G, Burton KJ, Pralong FP, Vionnet N, Capozzi F, Badertscher R, Vergeres G. Identification of Urinary Food Intake Biomarkers for Milk, Cheese, and Soy-Based Drink by Untargeted GC-MS and NMR in Healthy Humans. J Proteome Res. 2017 Sep 1;16(9):3321-3335. doi: 10.1021/acs.jproteome.7b00319. Epub 2017 Aug 10.

MeSH Terms

Interventions

CD36 AntigensHardness

Intervention Hierarchy (Ancestors)

Platelet Membrane GlycoproteinsMembrane GlycoproteinsGlycoproteinsGlycoconjugatesCarbohydratesFatty Acid Transport ProteinsMembrane Transport ProteinsCarrier ProteinsProteinsAmino Acids, Peptides, and ProteinsMembrane ProteinsReceptors, Cell SurfaceReceptors, ImmunologicScavenger Receptors, Class BReceptors, ScavengerReceptors, LDLReceptors, LipoproteinMechanical PhenomenaPhysical Phenomena

Study Officials

  • François Pralong, MD

    CHUV

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof, MD

Study Record Dates

First Submitted

March 5, 2016

First Posted

March 10, 2016

Study Start

August 1, 2015

Primary Completion

June 1, 2016

Study Completion

May 1, 2018

Last Updated

March 10, 2016

Record last verified: 2016-03

Locations